Prevalence of Catheter-associated bacteriuria in patients who received short-term catheterization in the northeast of Iran
Background: Catheter-associated (CA) bacteriuria is a result of the extensive usage of urinary catheterization. Once a catheter is placed, many patients achieve bacteriuria, even with the use of greatest consideration and care of the catheter. In this study, we decided to evaluate the prevalence of Catheter-associated bacteriuria in patients who received short-term catheterization in the northeast of Iran.
Materials and Methods: In this cross-sectional study during one year (among 2014-2015) 275 patients who have admitted recently and have no history of catheterization and drug consumption were included. Three samples were taken from patients before, one day after catheterization and after removal of the catheter. The urine samples were analyzed and cultured on the suitable media. Antibiotics susceptibility testing was performed by disk diffusion method. Then, data analyzed using SPSS software by Student t-test. In addition, the p values less than 0.05 were considered as significant.
Results: In general, the rate of catheter-associated bacteriuria in these hospitals was 68% (187 cases of 275). The mean age of the participants and patients with bacteriuria were 41±1.2 and 24.8±6.2 years old, respectively. The most common isolated bacteria were Escherichia coli (50.6%) followed by Staphylococcus aureus and Klebsiella pneumonia (21.6%). The highest sensitivity was reported against kanamycin (68.9%) and highest resistance was observed against ampicillin with a rate of 96.3%.
Conclusion: For prevention of healthcare-associated UTI, correct catheterization and use of the closed catheter system is recommended. In addition, before prescribing any antibiotics it should be paying attention to the antibiotics susceptibility testing results.
Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clinical infectious diseases. 2010;50(5):625-63.
Zhanel G, Harding G, Nicolle L. Asymptomatic bacteriuria in patients with diabetes mellitus. Review of Infectious Diseases. 1991;13(1):150-4.
Pediatrics AAo. Ten things physicians and patients should question2013.
Chaudhry A, Stone WJ, Breyer JA. Occurrence of pyuria and bacteriuria in asymptomatic hemodialysis patients. American journal of kidney diseases. 1993;21(2):180-3.
Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. Medical Clinics of North America. 2011;95(1):27-41.
Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clinical Infectious Diseases. 2005;40(5):643-54.
Nicolle LE. Asymptomatic bacteriuria in the elderly. Infectious disease clinics of North America. 1997;11(3):647-62.
Pratt RJ, Pellowe C, Loveday H. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). The Journal of hospital infection. 2001;47:S3-82.
Warren JW, Anthony WC, Hoopes JM, Muncie HL. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. Jama. 1982;248(4):454-8.
Vazquez JC, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev. 2011;1.
Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. The Lancet infectious diseases. 2010;10(1):43-50.
Khaledi A, Khademi F, Esmaeili D, Esmaeili S-A, Rostami H. ISSN 0975-413X CODEN (USA): PCHHAX.
Díez-Aguilar M, Morosini M-I, López-Cerero L, et al. Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes. Journal of Antimicrobial Chemotherapy. 2015;70(8):2306-10.
Zarb P, Coignard B, Griskeviciene J. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17(46):20316.
Nicolle LE. Catheter-associated urinary tract infections. Antimicrobial resistance and infection control. 2014;3(1):1.
Stark RP, Maki DG. Bacteriuria in the catheterized patient: what quantitative level of bacteriuria is relevant? New England Journal of Medicine. 1984;311(9):560-4.
Brennan BM, Coyle JR, Marchaim D. Statewide surveillance of carbapenem-resistant Enterobacteriaceae in Michigan. Infection Control & Hospital Epidemiology. 2014;35(04):342-349.
Lo E, Nicolle LE, Coffin SE, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infection Control & Hospital Epidemiology. 2014;35(S2):S32-S47.
Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Archives of internal medicine. 2000;160(5):678-82.
Acar J, Goldstein F. Trends in bacterial resistance to fluoroquinolones. Clinical Infectious Diseases. 1997;24(Supplement 1):S67-S73.
Leone M, Garnier F, Dubuc M, Bimar MC, Martin C. Prevention of nosocomial urinary tract infection in ICU patients: Comparison of effectiveness of two urinary drainage systems. CHEST Journal. 2001;120(1):220-4.
Amiri M, Lavasani Z, Norouzirad R. Prevalence of Urinary Tract Infection Among Pregnant Women and its Complications in Their Newborns During the Birth in the Hospitals of Dezful City, Iran, 2012-2013. Iranian Red Crescent Medical Journal. 2015;17(8).
Mojtahedzadeh M, Panahi Y, Fazeli MR, et al. Intensive care unit-acquired urinary tract infections in patients admitted with sepsis: etiology, risk factors, and patterns of antimicrobial resistance. International Journal of Infectious Diseases. 2008;12(3):312-8.
Alebiosu C, Osinupebi O, Olajubu F. Significant asymptomatic bacteriuria among Nigerian type 2 diabetics. Journal of the National Medical Association. 2003;95(5):344.
Sarrafzadeh F, Sohrevardi SM. Evaluation of bactereuria and antimicrobial Susceptibility among hospitalized patients with and without catheter in Kerman Province-Iran in 2011. Iranian Journal of Pharmaceutical Research. 2013;12(1):211-6.
Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL. Intensive care unit-acquired urinary tract infections in a regional critical care system. Critical Care. 2005;9(2):R60.
Wagenlehner F, Loibl E, Vogel H, Naber K. Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management. International journal of antimicrobial agents. 2006;28:86-90.
Savas L, Guvel S, Onlen Y, Savas N, Duran N. Nosocomial urinary tract infections: micro-organisms, antibiotic sensitivities and risk factors. West Indian medical journal. 2006;55(3):188-93.
Nordenstam GR, Brandberg CÅ, Odén AS, Svanborg Edén CM, Svanborg A. Bacteriuria and mortality in an elderly population. New England Journal of Medicine. 1986;314(18):1152-6.
Boroumand AM, Sam L, Abbasi HS, Salarifar M, Kassaian E, Forghani S. Asymptomatic bacteriuria in type 2 Iranian diabetic women: a cross sectional study. BMC Women's Health. 2006;6(1):1.
Sepehri G, Dabiri S, Vosoogh M. Comparison the Sensitivity of Microbial Agents Causing Urinary Tract Infections to Commonly Used Antibiotics in Kerman in the Years 1996 and 2000. Journal of Rafsanjan University of Medical Sciences. 2004;3(4):216-24.